wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28083595-3AC564D0-2217-44E2-AB2B-B6384563F660
Q28083595-3AC564D0-2217-44E2-AB2B-B6384563F660
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083595-3AC564D0-2217-44E2-AB2B-B6384563F660
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
P2860
Q28083595-3AC564D0-2217-44E2-AB2B-B6384563F660
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083595-3AC564D0-2217-44E2-AB2B-B6384563F660
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4334bc3a8e651b80f6e3458c94f67f87fee1475
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.